Close window

chemagen is now part of Revvity
Visit Revvity.com to see our full portfolio

Close window

SARS-CoV-2 sample pooling

Sample pooling for SARS-CoV-2 testing

Interested in sample pooling?

Interested in sample pooling?

Take a look on this interesting publication about efficient pooling for SARS-CoV-2 testing. The researchers have prepared 94 pools of 10 samples (a total of 940 nasopharyngeal swab samples) which were previously tested for SARS-CoV-2 and assigned them with random numbers. Then, they have used the pools for automated viral RNA purification and subsequent RT-PCR analysis to identify positive pools.

Please note that product labelling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.

SARS-CoV-2 variant detection

Variant identification

New solutions for SARS-CoV-2 variant identification

New solutions for SARS-CoV-2 variant detection

The observation of variants makes it necessary to take a deeper look on positive SARS-CoV-2 detection results. PerkinElmer has now developed two new solutions to identify variants of SARS-CoV-2.

The PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay is based on real-time RT-PCR multiplexing technology and enables the identification of known variants from positive samples (B1.1.7, B.1.351, P.1).

The NEXTFLEX® Variant Seq™ SARS-CoV-2 Kit for Illumina® sequencing enables the identification of existing and new variants of the SARS-CoV-2.

For research use only. Not for use in diagnostic procedures.

Please note that product labelling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.

chemagic 360 instrument in HIV research

chemagic 360 instrument for HIV research

chemagic™ 360 instrument for HIV studies

chemagic™ 360 instrument in HIV research

Take a look on this interesting publication and learn how the chemagic 360 instrument can help to study the human immunodeficiency virus. In this case the reduction of the HIV-1 integrase efficiency was determined in patients showing drug resistance mutations in reverse transcriptase.

Please note that product labelling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.